Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Are Vulnerable Hospitals Unfairly Penalized Over Readmission Rates?

June 2, 2016 By American College of Surgeons

Readmission rates after complex cancer operations tend to be higher in hospitals that are considered to be vulnerable because they serve as safety nets in their communities or have a high number of Medicaid patients. Reasons for higher readmission rates are highly complex and involve socioeconomic and hospital institutional characteristics. Payment programs that penalize hospitals for high readmission rates without understanding these issues could stress already financially threatened institutions, according to authors of a new study published online in the Journal of the American College of Surgeons in advance of print publication.

Clinical quality improvement efforts as well as federal payment policies have sought to reduce hospital readmissions to improve the quality of patient care and decrease Medicare program spending. A review of Medicare claims by the Medicare Payment Advisory Commission (MedPAC) in 2005 found that 5 to 79 percent of readmissions could potentially have been prevented and saved $12 billion in Medicare spending.

Findings such as these led to creation of the Medicare Hospital Readmissions Reduction Program (HRRP) in the Affordable Care Act, which penalizes hospitals that have higher than expected readmission rates. HRRP currently covers four common medical conditions–pneumonia, heart failure, acute myocardial infarction, and chronic obstructive pulmonary disease (COPD), along with two joint replacement operations (knee and hip). The program will expand in 2017 and begin including coronary artery bypass grafting (CABG) procedures.

Researchers found that patient factors were primary drivers of higher readmission rates to vulnerable hospitals after cancer operations.

While the American College of Surgeons has publicly recognized that high readmission rates may reflect lower quality care and lead to unnecessary spending, ACS has emphasized that readmissions may be related to many factors, including the complexity of the medical condition as well as patients’ socioeconomic status and compliance. ACS has urged HRRP to take such factors into consideration so hospitals are not penalized because of factors that are beyond their control.

In the present study, researchers found that patient factors were primary drivers of higher readmission rates to vulnerable hospitals after cancer operations. These results further support the need for incorporating socioeconomic variables into the determination of HRRP payments especially for hospitals that already serve a disproportionate number of disadvantaged patients.

“Patient conditions and hospital infrastructure make vulnerable hospitals prone to higher readmissions from the outset. Policymakers need to be aware of the drivers that lead to higher readmissions at these hospitals so payment penalties do not push financially strained hospitals into further hardship,” said Young Hong, MD, lead study investigator, MedStar-Georgetown Surgical Outcomes Research Center and Georgetown University Medical Center, Washington, D.C.

The researchers evaluated the care of 110,857 adult patients who had one of seven major or complex cancer procedures between January 1, 2004, and September 30, 2011, in one of 355 hospitals in the state of California. The researchers compared readmission rates for 311 non-vulnerable hospitals, 13 safety net hospitals, 31 high Medicaid institutions, and five hospitals that were both safety net and high Medicaid institutions. Patients underwent cancer resection procedures to remove the esophagus, stomach, pancreas, liver, prostate, lung, or kidney.

The 30-day readmission rates were 14 percent for safety net hospitals, 13 percent for high Medicaid hospitals, and 14 percent for safety net and high Medicaid institutions. Ninety-day readmission rates were 20 percent for safety net hospitals, 22 percent for high Medicaid hospitals, and 21 percent for high Medicaid and safety net hospitals. In contrast, the readmission rates for non-vulnerable hospitals were 11 percent at 30 days and 17 percent at 90 days.

Patients having cancer operations at vulnerable hospitals were more likely to live in low income areas (28 percent vs. 17 percent), have Medicaid (27 percent vs. 5 percent), and be admitted via the emergency department for their index procedure (15 percent vs 9 percent) than those who had their operations at non-vulnerable hospitals.

Patient cohorts differed in various types of vulnerable hospitals. The proportion of Hispanic patients was much higher (41 percent) at high Medicaid hospitals than at safety net (24 percent) or high Medicaid and safety net institutions (25 percent). High Medicaid and safety net institutions had a higher percentage of Medicaid patients (41 percent) than either of the other categories of vulnerable hospitals (27 percent for safety net hospitals and 24 percent for high Medicaid hospitals).

The vast majority of safety net and high Medicaid plus safety net institutions were teaching centers (85 percent and 100 percent, respectively), while 47 percent of high Medicaid hospitals had teaching programs.

“This study showed that the reasons behind higher readmissions may depend on the type of vulnerable hospital, given their varying patient populations and hospital characteristics,” said Chaoyi Zheng, MS, statistician for the study group.

Findings from this study reinforce ACS’s position that measures for determining financial penalties associated with hospital readmissions should focus on patient subgroups and socioeconomic factors.

“Different hospitals have different patient mixes, and if that is not factored in, HRRP reductions in payment may further marginalize financially vulnerable hospitals,” said corresponding study author Waddah B. Al-Refaie, MD, FACS, chief of surgical oncology, MedStar Georgetown University Hospital.

Related Articles Read More >

This is a Zimmer Biomet marketing image of its Rosa robotic surgery system.
Zimmer Biomet seeks a ZBEdge for its Rosa robotic surgery
A photo of Capstan Medical's mitral valve implant, which uses nitinol.
Capstan Medical’s R&D head discusses the heart valve and robotics startup’s tech, engineering challenges and solutions, advice for others in medtech and how to join his team
An illustration of a neurosurgeon using a robotic endoscope to remove a brain tumor.
MDO Nitinol Innovation Special Report
A photo of Highridge Medical CEO Rebecca Whitney.
Highridge Medical is betting on this spine tech
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe